Brassinin and its derivatives as potential anticancer agents.

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Brassinin derivatives are investigated for their potential anti-cancer properties.
• Understanding the mechanisms of action for novel anti-cancer compounds is crucial.

Purpose of the Study:

• To evaluate the anti-proliferative activity of brassinin and its derivatives on human cancer cell lines.
• To elucidate the molecular mechanisms underlying the anti-proliferative effects of 1-methoxybrassinin.

Main Methods:

• Screening of twenty-one brassinin derivatives for anti-proliferative activity.
• Flow cytometry to assess DNA content and apoptosis.
• DNA fragmentation assay to confirm apoptosis.
• Quantitative real-time PCR to analyze gene expression (Bax, Bcl-2, Bcl-xL).
• Assays for caspase activity, PARP cleavage, and intracellular glutathione (GSH) content.

Main Results:

• 1-methoxybrassinin demonstrated the most potent anti-proliferative activity against Caco-2 cells (IC50 = 8.2 ± 1.2 μmol/L).
• 1-methoxybrassinin induced apoptosis, evidenced by an increased sub-G1 DNA content and DNA fragmentation.
• Upregulation of pro-apoptotic Bax and downregulation of anti-apoptotic Bcl-2 and Bcl-xL genes were observed.
• Increased caspase-3, -7 activity, cleaved PARP, and decreased intracellular GSH content were noted.

Conclusions:

• 1-methoxybrassinin exhibits significant in vitro anti-proliferative and pro-apoptotic effects on human cancer cells.
• The compound's mechanism involves modulation of apoptosis-related genes and activation of caspases.
• These findings provide a strong rationale for further investigation of 1-methoxybrassinin in preclinical cancer models.